BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falzone L, Candido S, Salemi R, Basile MS, Scalisi A, McCubrey JA, Torino F, Signorelli SS, Montella M, Libra M. Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer. Oncotarget 2016;7:72758-66. [PMID: 27602581 DOI: 10.18632/oncotarget.11805] [Cited by in Crossref: 52] [Cited by in F6Publishing: 62] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Candido S, Tomasello B, Lavoro A, Falzone L, Gattuso G, Russo A, Paratore S, Mccubrey JA, Libra M. Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment. Front Cell Dev Biol 2022;10:945586. [DOI: 10.3389/fcell.2022.945586] [Reference Citation Analysis]
2 Guo Y, Zhang YB, Li Y, Su WH, He S, Pan SP, Xu K, Kou WH, Falzone L. Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma. International Journal of Genomics 2022;2022:1-35. [DOI: 10.1155/2022/3342666] [Reference Citation Analysis]
3 Simbulan-Rosenthal CM, Haribabu Y, Vakili S, Kuo LW, Clark H, Dougherty R, Alobaidi R, Carney B, Sykora P, Rosenthal DS. Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. Int J Mol Sci 2022;23:2333. [PMID: 35216449 DOI: 10.3390/ijms23042333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jhan JH, Hsu WC, Lee YC, Li WM, Huang AM, Lin HH, Wang CS, Wu YR, Li CC, Wu WJ, Ke HL. MicroRNA-375-3p Suppresses Upper Tract Urothelial Carcinoma Cell Migration and Invasion via Targeting Derlin-1. Cancers (Basel) 2022;14:880. [PMID: 35205628 DOI: 10.3390/cancers14040880] [Reference Citation Analysis]
5 Hamidi F, Gilani N, Belaghi RA, Sarbakhsh P, Edgünlü T, Santaguida P. Exploration of Potential miRNA Biomarkers and Prediction for Ovarian Cancer Using Artificial Intelligence. Front Genet 2021;12:724785. [PMID: 34899827 DOI: 10.3389/fgene.2021.724785] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Crescenzi E, Leonardi A, Pacifico F. NGAL as a Potential Target in Tumor Microenvironment. Int J Mol Sci 2021;22:12333. [PMID: 34830212 DOI: 10.3390/ijms222212333] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Yuan JH, Xie LS, Zhu YH, Wang XH, Zhang YJ, Wang XJ. Combination of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 are biomarkers for the detection of colon tubular adenocarcinoma . World J Gastrointest Oncol 2021; 13(10): 1506-1517 [PMID: 34721781 DOI: 10.4251/wjgo.v13.i10.1506] [Reference Citation Analysis]
8 Xu XL, Liu H, Zhang Y, Zhang SX, Chen Z, Bao Y, Li TK. SPP1 and FN1 are significant gene biomarkers of tongue squamous cell carcinoma. Oncol Lett 2021;22:713. [PMID: 34457068 DOI: 10.3892/ol.2021.12974] [Reference Citation Analysis]
9 Abdel-Hamid NM, Abass SA. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting. Mol Biol Rep 2021. [PMID: 34379286 DOI: 10.1007/s11033-021-06635-z] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Shi Y, Yan F, Wang F, Pan L. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells. Tissue Cell 2021;72:101534. [PMID: 33991762 DOI: 10.1016/j.tice.2021.101534] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Zhang X, Ma L, Zhai L, Chen D, Li Y, Shang Z, Zhang Z, Gao Y, Yang W, Li Y, Pan Y. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Int J Med Sci 2021;18:984-99. [PMID: 33456356 DOI: 10.7150/ijms.49126] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Rong L, Li H, Li Z, Ouyang J, Ma Y, Song F, Chen Y. FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway. Front Med (Lausanne) 2020;7:608441. [PMID: 33344485 DOI: 10.3389/fmed.2020.608441] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
13 Hui Z, Jiang Z, Qiao D, Bo Z, Qiyuan K, Shaohua B, Wenbing Y, Wei L, Cheng L, Shuangning L, Zhengyi L, Yingyi L. Increased expression of LCN2 formed a positive feedback loop with activation of the ERK pathway in human kidney cells during kidney stone formation. Sci Rep 2020;10:21287. [PMID: 33277533 DOI: 10.1038/s41598-020-75670-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Filetti V, Vitale E, Broggi G, Hagnäs MP, Candido S, Spina A, Lombardo C. Update of in vitro, in vivo and ex vivo fluoro-edenite effects on malignant mesothelioma: A systematic review (Review). Biomed Rep 2020;13:60. [PMID: 33149905 DOI: 10.3892/br.2020.1367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sato C, Osakabe M, Nagasawa T, Suzuki H, Itamochi H, Baba T, Sugai T. Genome-wide analysis of microRNA to evaluate prognostic markers in isolated cancer glands and surrounding stroma in high-grade serous ovarian carcinoma. Oncol Lett 2020;20:338. [PMID: 33123249 DOI: 10.3892/ol.2020.12198] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Falzone L, Grimaldi M, Celentano E, Augustin LSA, Libra M. Identification of Modulated MicroRNAs Associated with Breast Cancer, Diet, and Physical Activity. Cancers (Basel) 2020;12:E2555. [PMID: 32911851 DOI: 10.3390/cancers12092555] [Cited by in Crossref: 12] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
17 Nikolouzakis TK, Falzone L, Lasithiotakis K, Krüger-Krasagakis S, Kalogeraki A, Sifaki M, Spandidos DA, Chrysos E, Tsatsakis A, Tsiaoussis J. Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer. J Clin Med 2020;9:E2868. [PMID: 32899768 DOI: 10.3390/jcm9092868] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
18 Jing L, Wu J, Tang X, Ma M, Long F, Tian B, Lin C. Identification of circular RNA hsa_circ_0044556 and its effect on the progression of colorectal cancer. Cancer Cell Int 2020;20:427. [PMID: 32884449 DOI: 10.1186/s12935-020-01523-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zhang Y, Qin X, Jiang J, Zhao W. MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK/MAPK signaling pathway. Oncol Lett 2020;20:1327-35. [PMID: 32724375 DOI: 10.3892/ol.2020.11687] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Andl T, Ganapathy K, Bossan A, Chakrabarti R. MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology? Int J Mol Sci 2020;21:E4796. [PMID: 32645914 DOI: 10.3390/ijms21134796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
21 Hou X, Hou N, Fu J, He X, Xiong H, Xie W, Jia G, Zuo X, Qin X, Pang M. Identification of Key mRNAs and Pathways in Colorectal Cancer. Nutr Cancer 2021;73:1040-6. [PMID: 32586129 DOI: 10.1080/01635581.2020.1783328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Liu Y, Zhu DY, Xing HJ, Hou Y, Sun Y. A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients. J Biol Res (Thessalon) 2020;27:6. [PMID: 32477968 DOI: 10.1186/s40709-020-00116-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Costa C, Teodoro M, Rugolo CA, Alibrando C, Giambò F, Briguglio G, Fenga C. MicroRNAs alteration as early biomarkers for cancer and neurodegenerative diseases: New challenges in pesticides exposure. Toxicol Rep 2020;7:759-67. [PMID: 32612936 DOI: 10.1016/j.toxrep.2020.05.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
24 Napoli S, Scuderi C, Gattuso G, Bella VD, Candido S, Basile MS, Libra M, Falzone L. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma. Cells 2020;9:E1151. [PMID: 32392801 DOI: 10.3390/cells9051151] [Cited by in Crossref: 18] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
25 Filetti V, Falzone L, Rapisarda V, Caltabiano R, Eleonora Graziano AC, Ledda C, Loreto C. Modulation of microRNA expression levels after naturally occurring asbestiform fibers exposure as a diagnostic biomarker of mesothelial neoplastic transformation. Ecotoxicol Environ Saf 2020;198:110640. [PMID: 32330788 DOI: 10.1016/j.ecoenv.2020.110640] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
26 Vivarelli S, Falzone L, Basile MS, Candido S, Libra M. Nitric Oxide in Hematological Cancers: Partner or Rival? Antioxid Redox Signal 2021;34:383-401. [PMID: 32027171 DOI: 10.1089/ars.2019.7958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 La Rosa GRM, Gattuso G, Pedullà E, Rapisarda E, Nicolosi D, Salmeri M. Association of oral dysbiosis with oral cancer development. Oncol Lett 2020;19:3045-58. [PMID: 32211076 DOI: 10.3892/ol.2020.11441] [Cited by in Crossref: 13] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
28 Siokas V, Aslanidou P, Aloizou A, Peristeri E, Stamati P, Liampas I, Arseniou S, Drakoulis N, Aschner M, Tsatsakis A, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer’s Disease? J Mol Neurosci 2020;70:851-60. [DOI: 10.1007/s12031-020-01507-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
29 Cheng G, Xu D, Chu K, Cao Z, Sun X, Yang Y. The Effects of MiR-214-3p and Irisin/FNDC5 on the Biological Behavior of Osteosarcoma Cells. Cancer Biother Radiopharm 2020;35:92-100. [PMID: 32073886 DOI: 10.1089/cbr.2019.2933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
30 Liu T, Huang JZ, Lei ZY, Yan RS, Fan DL. FoxO3a depletion accelerates cutaneous wound healing by regulating epithelial‑mesenchymal transition through β‑catenin activation. Mol Med Rep 2020;21:1224-32. [PMID: 31922245 DOI: 10.3892/mmr.2020.10912] [Reference Citation Analysis]
31 Li L, Feng T, Zhang W, Gao S, Wang R, Lv W, Zhu T, Yu H, Qian B. MicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer. Int J Genomics 2020;2020:7415909. [PMID: 31976313 DOI: 10.1155/2020/7415909] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
32 Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, Kovatsi L, Spandidos DA, Drakoulis N, Kalogeraki A, Mamoulakis C, Tzanakakis G, Libra M, Tsatsakis A. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells 2019;8:E1251. [PMID: 31615102 DOI: 10.3390/cells8101251] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 9.7] [Reference Citation Analysis]
33 Qi Z, Yuan L, Sun N. Propofol exhibits a tumor-suppressive effect and regulates cell viability, migration and invasion in bladder carcinoma by targeting the microRNA-10b/HOXD10 signaling pathway. Oncol Lett 2019;18:6228-36. [PMID: 31788099 DOI: 10.3892/ol.2019.10968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
34 Simbulan-Rosenthal CM, Dougherty R, Vakili S, Ferraro AM, Kuo LW, Alobaidi R, Aljehane L, Gaur A, Sykora P, Glasgow E, Agarwal S, Rosenthal DS. CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis. Cancers (Basel) 2019;11:E1490. [PMID: 31623313 DOI: 10.3390/cancers11101490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
35 Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A. Current Perspectives in Cancer Immunotherapy. Cancers (Basel) 2019;11:E1472. [PMID: 31575023 DOI: 10.3390/cancers11101472] [Cited by in Crossref: 64] [Cited by in F6Publishing: 86] [Article Influence: 21.3] [Reference Citation Analysis]
36 Xu C, Meng LB, Duan YC, Cheng YJ, Zhang CM, Zhou X, Huang CB. Screening and identification of biomarkers for systemic sclerosis via microarray technology. Int J Mol Med 2019;44:1753-70. [PMID: 31545397 DOI: 10.3892/ijmm.2019.4332] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
37 Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD, Tsatsakis A. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics. Cells 2019;8:E863. [PMID: 31405017 DOI: 10.3390/cells8080863] [Cited by in Crossref: 62] [Cited by in F6Publishing: 83] [Article Influence: 20.7] [Reference Citation Analysis]
38 Falzone L, Scola L, Zanghì A, Biondi A, Di Cataldo A, Libra M, Candido S. Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development. Aging (Albany NY) 2018;10:1000-14. [PMID: 29779016 DOI: 10.18632/aging.101444] [Cited by in Crossref: 82] [Cited by in F6Publishing: 104] [Article Influence: 27.3] [Reference Citation Analysis]
39 Candido S, Lupo G, Pennisi M, Basile MS, Anfuso CD, Petralia MC, Gattuso G, Vivarelli S, Spandidos DA, Libra M, Falzone L. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease. Oncol Rep 2019;42:911-22. [PMID: 31322245 DOI: 10.3892/or.2019.7215] [Cited by in Crossref: 34] [Cited by in F6Publishing: 54] [Article Influence: 11.3] [Reference Citation Analysis]
40 Liu X, Wu Y, Zhou Z, Huang M, Deng W, Wang Y, Zhou X, Chen L, Li Y, Zeng T, Wang G, Fu B. Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis. Int J Mol Med 2019;44:683-93. [PMID: 31198976 DOI: 10.3892/ijmm.2019.4241] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
41 Teodoro M, Briguglio G, Fenga C, Costa C. Genetic polymorphisms as determinants of pesticide toxicity: Recent advances. Toxicol Rep 2019;6:564-70. [PMID: 31293901 DOI: 10.1016/j.toxrep.2019.06.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
42 Vivarelli S, Falzone L, Basile M, Nicolosi D, Genovese C, Libra M, Salmeri M. Benefits of using probiotics as adjuvants in anticancer therapy (Review). Wrld Acd Sci 2019. [DOI: 10.3892/wasj.2019.13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
43 Falzone L, Lupo G, La Rosa GRM, Crimi S, Anfuso CD, Salemi R, Rapisarda E, Libra M, Candido S. Identification of Novel MicroRNAs and Their Diagnostic and Prognostic Significance in Oral Cancer. Cancers (Basel) 2019;11:E610. [PMID: 31052345 DOI: 10.3390/cancers11050610] [Cited by in Crossref: 52] [Cited by in F6Publishing: 63] [Article Influence: 17.3] [Reference Citation Analysis]
44 Zhu W, Liu H, Wang X, Lu J, Yang W. Long noncoding RNAs in bladder cancer prognosis: A meta-analysis. Pathol Res Pract 2019;215:152429. [PMID: 31064722 DOI: 10.1016/j.prp.2019.04.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
45 Mejias A, Diez-Hermano S, Ganfornina MD, Gutierrez G, Sanchez D. Characterization of mammalian Lipocalin UTRs in silico: Predictions for their role in post-transcriptional regulation. PLoS One 2019;14:e0213206. [PMID: 30840684 DOI: 10.1371/journal.pone.0213206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
46 Wang X, Li Z, Bai J, Song W, Zhang F. miR‑17‑5p regulates the proliferation and apoptosis of human trabecular meshwork cells by targeting phosphatase and tensin homolog. Mol Med Rep 2019;19:3132-8. [PMID: 30816540 DOI: 10.3892/mmr.2019.9973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
47 Falzone L, Romano GL, Salemi R, Bucolo C, Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M, Candido S. Prognostic significance of deregulated microRNAs in uveal melanomas. Mol Med Rep 2019;19:2599-610. [PMID: 30816460 DOI: 10.3892/mmr.2019.9949] [Cited by in Crossref: 34] [Cited by in F6Publishing: 54] [Article Influence: 11.3] [Reference Citation Analysis]
48 Yuan J, Dong R, Liu F, Zhan L, Liu Y, Wei J, Wang N. The miR-183/182/96 cluster functions as a potential carcinogenic factor and prognostic factor in kidney renal clear cell carcinoma. Exp Ther Med 2019;17:2457-64. [PMID: 30906433 DOI: 10.3892/etm.2019.7221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
49 Monteiro-Reis S, Lobo J, Henrique R, Jerónimo C. Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer. Int J Mol Sci 2019;20:E297. [PMID: 30642115 DOI: 10.3390/ijms20020297] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
50 Nie W, Ni D, Ma X, Zhang Y, Gao Y, Peng C, Zhang X. miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3. Int J Oncol 2019;54:559-71. [PMID: 30483771 DOI: 10.3892/ijo.2018.4636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
51 Salemi R, Falzone L, Madonna G, Polesel J, Cinà D, Mallardo D, Ascierto PA, Libra M, Candido S. MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA. Front Pharmacol 2018;9:856. [PMID: 30154717 DOI: 10.3389/fphar.2018.00856] [Cited by in Crossref: 37] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
52 Chappell WH, Candido S, Abrams SL, Russo S, Ove R, Martelli AM, Cocco L, Ramazzotti G, Cervello M, Montalto G, Steelman LS, Leng X, Arlinghaus RB, Libra M, Mccubrey JA. Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines. Advances in Biological Regulation 2018;69:43-62. [DOI: 10.1016/j.jbior.2018.05.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
53 Gao JM, Huang LZ, Huang ZG, He RQ. Clinical value and potential pathways of miR-183-5p in bladder cancer: A study based on miRNA-seq data and bioinformatics analysis. Oncol Lett 2018;15:5056-70. [PMID: 29616090 DOI: 10.3892/ol.2018.7967] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
54 Mao XW, Xiao JQ, Li ZY, Zheng YC, Zhang N. Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway. Exp Mol Med 2018;50:e429. [PMID: 29350680 DOI: 10.1038/emm.2017.239] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
55 Leonardi GC, Accardi G, Monastero R, Nicoletti F, Libra M. Ageing: from inflammation to cancer. Immun Ageing 2018;15:1. [PMID: 29387133 DOI: 10.1186/s12979-017-0112-5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 18.0] [Reference Citation Analysis]
56 Singh R, Mandhani A, Agrawal V, Garg M. Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients. Cancer Microenviron 2018;11:23-39. [PMID: 29349669 DOI: 10.1007/s12307-017-0199-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
57 Wieczorek E, Reszka E. mRNA, microRNA and lncRNA as novel bladder tumor markers. Clin Chim Acta 2018;477:141-53. [PMID: 29224950 DOI: 10.1016/j.cca.2017.12.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 7.4] [Reference Citation Analysis]
58 Peng Z, Jia J, Gong W, Gao X, Ma P, Jin Z, Fan Y, Li Y, Zhang X. The association of matrix metalloproteinase-9 promoter polymorphisms with gastric cancer risk: a meta-analysis. Oncotarget 2017;8:99024-32. [PMID: 29228747 DOI: 10.18632/oncotarget.20931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
59 Ecke TH, Stier K, Weickmann S, Zhao Z, Buckendahl L, Stephan C, Kilic E, Jung K. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy. Cancer Med 2017;6:2252-62. [PMID: 28879675 DOI: 10.1002/cam4.1161] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
60 Xu Y, Qin S, An T, Tang Y, Huang Y, Zheng L. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method. Prostate 2017;77:1167-75. [PMID: 28617988 DOI: 10.1002/pros.23376] [Cited by in Crossref: 34] [Cited by in F6Publishing: 48] [Article Influence: 6.8] [Reference Citation Analysis]
61 Ding Y, Pan Y, Liu S, Jiang F, Jiao J. Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV. Cancer Biol Ther 2017;18:414-24. [PMID: 28613134 DOI: 10.1080/15384047.2017.1323585] [Cited by in Crossref: 20] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
62 Qi X, Shao M, Sun H, Shen Y, Meng D, Huo W. Long non-coding RNA SNHG14 promotes microglia activation by regulating miR-145-5p/PLA2G4A in cerebral infarction. Neuroscience 2017;348:98-106. [DOI: 10.1016/j.neuroscience.2017.02.002] [Cited by in Crossref: 75] [Cited by in F6Publishing: 85] [Article Influence: 15.0] [Reference Citation Analysis]